References
- van Roijen L, Koopmanschap MA, Rutten FF, van der Maas PJ. Indirect costs of disease; an international comparison. Health Policy 1995;33(1):15-29
- ZUS Statistical Portal. Available from: www.psz.zus.pl/
- Krol M, Brouwer W. How to Estimate Productivity Costs in Economic Evaluations. Pharmacoeconomics 2014;32:335-44
- Central Statistical Office of Poland. Available from: http://stat.gov.pl/en/ [Last accessed February 2015]
- National Bank of Poland. Available from: http://nbp.pl/homen.aspx?f=/srodeken.htm [Last accessed November 2014]
- Huscher D, Mittendorf T, von Hinüber U, et al. Evolution of cost structures in rheumatoid arthritis over the past decade. Ann Rheum Dis 2014. [Epub ahead of print]
- Parés-Badell O, Barbaglia G, Jerinic P, et al. Cost of disorders of the brain in Spain. PLoS One 2014;9(8):e105471
- Steinke SI, Peitsch WK, Ludwig A, Goebeler M. Cost-of-illness in psoriasis: comparing inpatient and outpatient therapy. PLoS One 2013;8(10):e78152
- Hex N, Bartlett C, Wright D, et al. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med 2012;29(7):855-62
- Cohen RD, Yu AP, Wu EQ, et al. Systematic review: the costs of ulcerative colitis in Western countries. Aliment Pharmacol Ther 2010;31(7):693-707
- Chiang JL, Kirkman MS, Laffel LM, Peters AL. Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care 2014;37(7):2034-54
- Beran D. Developing a hierarchy of needs for Type 1 diabetes. Diabet Med 2014;31(1):61-7
- Johnson B, Elliott J, Scott A, et al. Medical and psychological outcomes for young adults with Type 1 diabetes: no improvement despite recent advances in diabetes care. Diabet Med 2014;31(2):227-31
- Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 2009;11(3):229
- Guillemin F, Saraux A, Guggenbuhl P, et al. Prevalence of rheumatoid arthritis in France: 2001. Ann Rheum Dis 2005;64(10):1427-30
- Kim GE, Seidler E, Kimball AB. Effect of age at diagnosis on chronic quality of life and long-term outcomes of individuals with psoriasis. Pediatr Dermatol 2014; Epub ahead of print
- Milo R, Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev 2010;9(5):A387-94
- Büsch K, Ludvigsson JF, Ekström-Smedby K, et al. Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study. Aliment Pharmacol Ther 2014;39(1):57-68